A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
26 07 2019
Historique:
received: 11 04 2018
revised: 31 01 2019
accepted: 14 02 2019
pubmed: 11 3 2019
medline: 17 9 2020
entrez: 11 3 2019
Statut: ppublish

Résumé

The objective of the present study was to investigate the risk factors for intussusception (IS) among infants, including vaccination against rotavirus. Case-control study with systematic inclusion of all infants aged <1 year with suspected IS admitted to emergency departments in the eastern region of France between 1 April 2008 and 31 March 2012. All cases classed level 1 according to the Brighton classification were matched to 4 hospital controls. Two exposure windows were examined; exposure to the first dose of rotavirus vaccine in the 7 and in the 14 days prior to the occurrence of IS. A total of 115 cases were matched with 457 controls. The average vaccination coverage rate over the 4 years of study was 8.6%. Rotavirus vaccine was not found to be significantly associated with the occurrence of IS in the 7 days (odds ratio (OR) not calculated; p = 0.99) and in the 14 days after administration of one dose vaccine (OR 1.33, 95% confidence interval (CI) 0.14-12.82). Infant formula alone or combined with breastfeeding was associated with an excess risk of IS (OR 2.74, 95% CI 1.10-6.79). A history of gastroenteritis within 2 weeks prior to hospitalisation was also associated with an increased risk (OR 2.24, 95% CI 1.07-4.67). Our study indicates that infant formula alone or combined with breastfeeding is a risk factor for IS. A small, non-significant increase in the risk of IS was observed after rotavirus vaccination, although the low vaccine coverage rate likely precluded detection of a significant increase in risk.

Identifiants

pubmed: 30851968
pii: S0264-410X(19)30260-9
doi: 10.1016/j.vaccine.2019.02.053
pii:
doi:

Substances chimiques

Rotavirus Vaccines 0
Vaccines, Attenuated 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4587-4593

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Arnaud Fotso Kamdem (A)

Department of Pediatric Surgery, Besançon University Hospital, F-25000 Besançon, France. Electronic address: afotsokamdem@chu-besancon.fr.

Chrystelle Vidal (C)

INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: c1vidal@chu-besancon.fr.

Lionel Pazart (L)

INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: lpazart@chu-besancon.fr.

Franck Leroux (F)

INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: f1leroux@chu-besancon.fr.

Aurore Pugin (A)

INSERM-CIC-1431, Besançon University Hospital, F-25000 Besançon, France. Electronic address: avivot@chu-besancon.fr.

Caroline Savet (C)

Phisquare Institute, Transplantation Foundation, F-75015 Paris, France. Electronic address: c1marmier@chu-besancon.fr.

Geoffroy Sainte-Claire Deville (G)

Phisquare Institute, Transplantation Foundation, F-75015 Paris, France. Electronic address: geoffroy.sainteclairedeville.ext@aixial.com.

Didier Guillemot (D)

INSERM UMR 1181 « Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases » (B2PHI), F-75015 Paris, France; Institut Pasteur, UMR 1181, B2PHI, F-75015 Paris, France; University of Versailles St Quentin, UMR 1181, B2PHI, F-78180 Montigny-le-Bretonneux, France; AP-HP, Raymond Poincare Hospital, F-92380 Garches, France. Electronic address: didier.guillemot@pasteur.fr.

Jacques Massol (J)

Phisquare Institute, Transplantation Foundation, F-75015 Paris, France. Electronic address: jacques.massol.ext@aixial.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH